Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
New Data Showed SYMBICORT® Significantly Improved Small Airway Function in Asthma Patients
April 3rd, 2009
Results from three newly presented studies evaluating the maintenance combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dihydrate), showed significant improvement in small airway function in patients ages 12 years and older with asthma previously receiving inhaled corticosteroid (ICS) therapy.1,2 Small airways play an important role in the disease, and treatments that go beyond the central airways to reach the small airways may offer benefits in controlling persistent asthma.1,2 Two 12-week studies (Poster 602) and one 52-week study (Poster 291) demonstrated that SYMBICORT provided greater improvements in small airway function compared to its mono-components,...
Source: Health Business Week (2009-04-03)
|
